M&A Deal Summary

Scope Acquires Eyetamins

On October 17, 2024, Scope acquired food company Eyetamins

Acquisition Highlights
  • This is Scope’s 1st transaction in the Food sector.
  • This is Scope’s 1st transaction in the United States.
  • This is Scope’s 1st transaction in New York.

M&A Deal Summary
Date 2024-10-17
Target Eyetamins
Sector Food
Buyer(s) Scope
Deal Type Add-on Acquisition

Target

Eyetamins

New York, New York, United States
Eyetamins offers a range of innovative eye supplements made with carefully sourced and clinically backed ingredients to support eye health and vision. Eyetamins is based in New York.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Scope

Dublin, United Kingdom
Category Company
Sector Medical Products
DESCRIPTION

Scope is an international healthcare company. It offers innovative products for the management of ocular surface disease (e.g. Dry Eye/Blepharitis/MGD) and age-related macular degeneration. Scope was founded in 2009 and is based in Dublin, United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector (Food) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New York) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal